atropine has been researched along with guanabenz in 5 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (guanabenz) | Trials (guanabenz) | Recent Studies (post-2010) (guanabenz) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 446 | 42 | 96 |
| Protein | Taxonomy | atropine (IC50) | guanabenz (IC50) |
|---|---|---|---|
| trace amine-associated receptor 1 | Homo sapiens (human) | 1.173 | |
| Solute carrier family 22 member 1 | Homo sapiens (human) | 4.85 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.204 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.041 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.149 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.106 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.068 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.787 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.472 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.392 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.204 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 2.068 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.097 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Hall, AH; Kulig, KW; Rumack, BH; Smolinske, SC | 1 |
| Berridge, TL; Gadie, B; Roach, AG; Tulloch, IF | 1 |
5 other study(ies) available for atropine and guanabenz
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Guanabenz overdose.
Topics: Atropine; Bradycardia; Child, Preschool; Dopamine; Female; Fluid Therapy; Guanabenz; Guanidines; Humans; Hypotension; Middle Aged; Naloxone; Sleep Stages | 1985 |
alpha 2-Adrenoceptor agonists induced mydriasis in the rat by an action within the central nervous system.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Atropine; Brain; Dioxins; Epinephrine; Guanabenz; Idazoxan; Injections, Intraventricular; Male; Mydriatics; Physostigmine; Pupil; Rats; Rats, Inbred Strains | 1983 |